Alemtuzumab Intravenous and Buprenorphine/naloxone Oromucosal, Sublingual
Determining the interaction of Alemtuzumab Intravenous and Buprenorphine/naloxone Oromucosal, Sublingual and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: buprenorphine / naloxone
Brand name: Bunavail, Suboxone, Zubsolv
Synonyms: Buprenorphine and naloxone (oral/sublingual), Buprenorphine and Naloxone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Buproban
- Alemtuzumab Intravenous-Bupropion
- Alemtuzumab Intravenous-Bupropion and naltrexone
- Alemtuzumab Intravenous-Bupropion Extended-Release Tablets
- Alemtuzumab Intravenous-Bupropion Hydrochloride
- Alemtuzumab Intravenous-Bupropion SR Tablets
- Buprenorphine/naloxone Oromucosal, Sublingual-Alenaze-D
- Buprenorphine/naloxone Oromucosal, Sublingual-Alendronate
- Buprenorphine/naloxone Oromucosal, Sublingual-Alendronate and cholecalciferol
- Buprenorphine/naloxone Oromucosal, Sublingual-Alendronate Effervescent Tablets
- Buprenorphine/naloxone Oromucosal, Sublingual-Alendronate Oral Solution
- Buprenorphine/naloxone Oromucosal, Sublingual-Alendronate Sodium